Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Resende, L.S.A

Resende, L.S.A

HRAN – Regional Hospital, Brazil

Title: Brazilian national screening program of cervical cancer: Critical analysis

Biography

Biography: Resende, L.S.A

Abstract

Introduction: Cervical cancer ranks third in prevalence and fourth as cause of death in women worldwide in Brazil, 17,540 women were diagnosed in 2012. Screening of precursor lesions of cervical cancer is done through the annual collection of cytology (Pap smear test) in women aged 25-64 and sexually active. Objective: Demonstrate poor adherence of the target population for screening for precursor lesions of cervical cancer in Brazil due to the current program adopted by the national health agency. Exhibit the prevalence of precursor lesions of cervical cancer in Brazil. Methods: All information was obtained by consulting the INCA (National Institute of Cancer) database and Federal District Health Department. Non-parametric tests were performed.Chi-squares (and Fisher’s Exact test where appropriate) were used to compare the prevalence of cytological abnormalities. Results: 27% of eligible women participated in the screening program in 2013-2014 and less than 1% were referred for colposcopy. The frequencies of cytological abnormalities were ASC-H (0.41%); AGC-HSIL (0.09%); HSIL (0.56%); invasive carcinoma (0.04%); adenocarcinoma in situ (0.03%) and invasive adenocarcinoma (0.01%). Discussion: The current screeningof precursor lesions of cervical cancer adopted in Brazil is not organized and has low catch-up program adherence. Women aged 25-64 are first attended for a primary screening and referred to a trained colposcopist if abnormal cytological result detected. Women's target population in Brasilia as the capital of Brazil is nearly 900,000 individuals. However, in the current program, few women have cytology collected annually and has a minority colposcopic assessment if necessary.